AstraZeneca rolls up cardiovascular, renal and metabolic interconnections in film and digital effort
AstraZeneca is putting its cardiovascular, renal and metabolic (CVRM) portfolio in the spotlight with a short film and digital campaign. The two-minute video lays out AstraZeneca’s ambitions across the “complex and interconnected” diseases.
“By 2032, we aim to be leading the world in CVRM therapies, with as many as 15 life-changing new medicines developed and delivered by making the connections that empower us to fulfill our ambition and stop, and one day, cure these diseases,” the narrator says.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.